GBA
ACAD icon

Garrison Bradford & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,800
Closed -$227K 53
2021
Q1
$227K Hold
8,800
0.25% 46
2020
Q4
$470K Buy
8,800
+2,979
+51% +$159K 0.57% 33
2020
Q3
$240K Sell
5,821
-100
-2% -$4.12K 0.34% 41
2020
Q2
$287K Hold
5,921
0.42% 35
2020
Q1
$250K Sell
5,921
-600
-9% -$25.3K 0.43% 34
2019
Q4
$279K Buy
6,521
+621
+11% +$26.6K 0.35% 39
2019
Q3
$212K Sell
5,900
-22,800
-79% -$819K 0.29% 46
2019
Q2
$767K Sell
28,700
-3,000
-9% -$80.2K 0.9% 27
2019
Q1
$851K Sell
31,700
-1,000
-3% -$26.8K 0.72% 30
2018
Q4
$529K Sell
32,700
-15,800
-33% -$256K 0.48% 37
2018
Q3
$1.01M Sell
48,500
-5,000
-9% -$104K 0.81% 23
2018
Q2
$817K Sell
53,500
-15,500
-22% -$237K 0.67% 27
2018
Q1
$1.55M Sell
69,000
-5,150
-7% -$116K 1.32% 17
2017
Q4
$2.23M Buy
74,150
+800
+1% +$24.1K 1.85% 14
2017
Q3
$2.76M Sell
73,350
-500
-0.7% -$18.8K 2.31% 12
2017
Q2
$2.06M Buy
73,850
+1,300
+2% +$36.3K 1.78% 14
2017
Q1
$2.49M Hold
72,550
2.2% 13
2016
Q4
$2.09M Buy
72,550
+3,000
+4% +$86.5K 1.93% 15
2016
Q3
$2.21M Sell
69,550
-550
-0.8% -$17.5K 2.08% 14
2016
Q2
$2.28M Sell
70,100
-3,700
-5% -$120K 2.23% 13
2016
Q1
$2.06M Buy
73,800
+11,400
+18% +$319K 2.4% 14
2015
Q4
$2.23M Buy
62,400
+14,850
+31% +$530K 2.49% 12
2015
Q3
$1.57M Buy
47,550
+7,450
+19% +$246K 1.74% 16
2015
Q2
$1.68M Buy
40,100
+20,000
+100% +$837K 1.64% 18
2015
Q1
$655K Buy
20,100
+8,350
+71% +$272K 0.61% 38
2014
Q4
$373K Sell
11,750
-2,500
-18% -$79.4K 0.34% 64
2014
Q3
$353K Sell
14,250
-200
-1% -$4.95K 0.35% 63
2014
Q2
$326K Buy
14,450
+2,400
+20% +$54.1K 0.3% 73
2014
Q1
$293K Sell
12,050
-100
-0.8% -$2.43K 0.28% 74
2013
Q4
$304K Buy
+12,150
New +$304K 0.29% 66